Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety and immunogenicity of double-dose versus standard-dose hepatitis B revaccination in non-responding adults with HIV-1 (ANRS HB04 B-BOOST): a multicentre, open-label, randomised controlled trial.
Rey D, Piroth L, Wendling MJ, Miailhes P, Michel ML, Dufour C, Haour G, Sogni P, Rohel A, Ajana F, Billaud E, Molina JM, Launay O, Carrat F; ANRS HB04 B-BOOST study group. Rey D, et al. Among authors: wendling mj. Lancet Infect Dis. 2015 Nov;15(11):1283-91. doi: 10.1016/S1473-3099(15)00220-0. Epub 2015 Aug 6. Lancet Infect Dis. 2015. PMID: 26257021 Clinical Trial.
[Hepatitis A seroprevalence in HIV-infected patients].
Rey D, Frick-Michot E, Partisani M, Hess-Kempf G, Cheneau C, Priester M, Bernard-Henry C, de Mautort E, Wendling MJ, Meyer P, Lang JM. Rey D, et al. Among authors: wendling mj. Med Mal Infect. 2005 Jul-Aug;35(7-8):402-6. doi: 10.1016/j.medmal.2005.05.003. Med Mal Infect. 2005. PMID: 16139462 French.
Vaccination Against Hepatitis B Virus (HBV) in HIV-1-Infected Patients With Isolated Anti-HBV Core Antibody: The ANRS HB EP03 CISOVAC Prospective Study.
Piroth L, Launay O, Michel ML, Bourredjem A, Miailhes P, Ajana F, Chirouze C, Zucman D, Wendling MJ, Nazzal D, Carrat F, Rey D, Binquet C; ANRS HB EP03 CISOVAC Study Group. Piroth L, et al. Among authors: wendling mj. J Infect Dis. 2016 Jun 1;213(11):1735-42. doi: 10.1093/infdis/jiw011. Epub 2016 Jan 14. J Infect Dis. 2016. PMID: 26768256 Clinical Trial.
Sex Differences in the Evolution of Neutralizing Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2.
Grzelak L, Velay A, Madec Y, Gallais F, Staropoli I, Schmidt-Mutter C, Wendling MJ, Meyer N, Planchais C, Rey D, Mouquet H, Reix N, Glady L, Hansmann Y, Bruel T, De Sèze J, Fontanet A, Gonzalez M, Schwartz O, Fafi-Kremer S. Grzelak L, et al. Among authors: wendling mj. J Infect Dis. 2021 Sep 17;224(6):983-988. doi: 10.1093/infdis/jiab127. J Infect Dis. 2021. PMID: 33693749 Free PMC article.
Evolution of antibody responses up to 13 months after SARS-CoV-2 infection and risk of reinfection.
Gallais F, Gantner P, Bruel T, Velay A, Planas D, Wendling MJ, Bayer S, Solis M, Laugel E, Reix N, Schneider A, Glady L, Panaget B, Collongues N, Partisani M, Lessinger JM, Fontanet A, Rey D, Hansmann Y, Kling-Pillitteri L, Schwartz O, De Sèze J, Meyer N, Gonzalez M, Schmidt-Mutter C, Fafi-Kremer S. Gallais F, et al. Among authors: wendling mj. EBioMedicine. 2021 Sep;71:103561. doi: 10.1016/j.ebiom.2021.103561. Epub 2021 Aug 27. EBioMedicine. 2021. PMID: 34455390 Free PMC article.
COVID-19 exposure in SARS-CoV-2-seropositive hospital staff members during the first pandemic wave at Strasbourg University Hospital, France.
Velay A, Gallais F, Wendling MJ, Bayer S, Reix N, Schneider A, Glady L, Collongues N, Lessinger JM, Hansmann Y, Kling-Pillitteri L, De Sèze J, Gonzalez M, Schmidt-Mutter C, Meyer N, Fafi-Kremer S. Velay A, et al. Among authors: wendling mj. Infect Dis Now. 2022 Feb;52(1):23-30. doi: 10.1016/j.idnow.2021.11.002. Epub 2021 Nov 11. Infect Dis Now. 2022. PMID: 34775140 Free PMC article.
Tick-borne encephalitis in pediatrics: An often overlooked diagnosis.
Parfut A, Laugel E, Baer S, Gonzalez G, Hansmann Y, Wendling MJ, Fafi-Kremer S, Velay A. Parfut A, et al. Among authors: wendling mj. Infect Dis Now. 2023 Mar;53(2):104645. doi: 10.1016/j.idnow.2023.01.005. Epub 2023 Jan 13. Infect Dis Now. 2023. PMID: 36642097 Review.
Evaluation of the performance of SARS-CoV-2 serological tools and their positioning in COVID-19 diagnostic strategies.
Velay A, Gallais F, Benotmane I, Wendling MJ, Danion F, Collange O, De Sèze J, Schmidt-Mutter C, Schneider F, Bilbault P, Meziani F, Fafi-Kremer S. Velay A, et al. Among authors: wendling mj. Diagn Microbiol Infect Dis. 2020 Dec;98(4):115181. doi: 10.1016/j.diagmicrobio.2020.115181. Epub 2020 Aug 21. Diagn Microbiol Infect Dis. 2020. PMID: 32957073 Free PMC article.
29 results